Bridging the Gap: Conference Record [Abstract book, International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference Abstracts 60356-60360 1065 to work in brothel complexes, and to have more customers per week than other sex workers. The prevalence rates of syphilis, gonorrhea, chlamydia, and trichomoniasis were higher among sex workers who received the routine penicillin treatment than among those who had not received antibiotic treatment in the last 28 days. However, after adjustment for age, education, fee per sex act, number of customers, and condom use in the previous 7 days, only trichomoniasis was still significantly different (adjusted odds ratio of 3.2). Conclusion: High risk women were more likely to participate in the routine penicillin prophylaxis program. The lack of a demonstrable individual-level protection from this prophylaxis treatment program in this cross-sectional study appears due to differential uptake of penicillin prophylaxis by women at higher presumptive risk for STD. Randomized clinical trials and mathematical modeling, together with observational data such as presented here, all can contribute to optimal understanding of a complex intervention like mass chemoprophylaxis for STD among female sex workers. S60356 | Adherence to HAART in clinical trials vs. clinical care setting Katrin Bergeron1, J. Gormley1, H. Sousa1, K. Tashima2, T.P. Flanigan2, N.A. Merriman. ' The Miriam Hospital, 164 Summit Ave, Providence RI 02906; 2Miriam Hospital Brown University, Providence RI, USA Issue: Do clinical trials enhance adherence to highly active antiretroviral therapy (HAART) in a comprehensive care setting? Methods: A retrospective chart review was conducted to compare adherence among individuals enrolled in open-label drug trials to a randomly selected group of individuals receiving prescription antiretrovirals in the same clinical care setting. The two groups were similar with respect to age, sex, race, amount of time on therapy, and viral load prior to initiating HAART. Plasma viral load (PVL) was used as the primary measure of adherence. Results: Participation in clinical trials enhanced adherence to HAART when compared to a similar group receiving prescription antiretrovirals in the same clinical setting. Fifty-one individuals in clinical trials at our site completed >3 months (median 6 months) of open label therapy and were included in this analysis. 84% (43/51) of the clinical trial group had a most recent PVL of <.400 copies/mL. The comparison group of patients received prescription antiretrovirals within the same clinical setting. 59% (15/36) of those taking HAART by prescriptions had a most recent PVL of -400 copies/mL. The prevalence of prior antiretroviral therapy was higher in the group of individuals receiving prescriptions. Therefore, a subset analysis was done on the individuals receiving prescriptions who were naive to treatment prior to initiating HAART. Among these 60% (9/15) had a most recent PVL of -400 copies/mL. Conclusions: In a clinical trials setting, 84% of patients on HAART had PVL -400. The adherence techniques employed in clinical trials need to be explored in clinical settings to improve adherence and impact on viral load suppression. 60357 Prevention of Pneumocystis carinii pneumonia: The incarcerated Abe Macher1, E. Goosby2, D. Von Zinkernagel2. 1560 Fishers Lane Room 7A-55, Rockville MD 20857; 2U.S. Public Health Service, Washington DC, USA Issue: As increasing numbers of HIV-infected substance abusers enter correctional facilities, their morbidity will be directly related to the implementation of standard-of-care prophylactic regimens for the prevention of opportunistic infections. Project: We reviewed the medical records of four HIV-infected inmates with a history of injection drug use who were admitted from prison to a city hospital for diagnosis and treatment of Pneumocystis carinii pneumonia (PCP). Results: Although all four inmates had CD4+ T-lymphocyte counts below 200, none had been receiving prophylaxis for the prevention of PCP during their incarcerations. progression-free survival and changes in CD4 cell counts and serum viral RNA. Methods: Data were used from a clinical endpoint study of IDV 800 mg q8h vs. ZDV 200 mg q8h vs. IDV+ZDV in 996 treatment-naive HIV-1 infected patients with 50-250 CD4 cells/mm3. Clinical efficacy was assessed by evaluating time from initiation of therapy to the first clinical event (AIDS-defining condition or death). CD4 and vRNA were measured in all patients. Lamivudine (3TC) was added to the regimens of most patients in the IDV+ZDV and ZDV groups during the study (median 40 wks). Results: 716 patients (72%) were male and 280 (28%) were female. 84 (11.7%) and 23 (8.2%) of the male and female patients, respectively, experienced a clinical event. For both genders, the IDV-containing regimens resulted in marked decreases in vRNA and increases in CD4 cell counts relative to the ZDV arm. IDV+ZDV vs. ZDV Overall Males Females IDV vs. ZDV Overall Males Females Percent Reduction in Hazards of Clinical Event (95% Cl) 70% (50%, 82%) 77% (58%, 88%) 38% ( 58%, 76%) 61% (38%, 76%) 61% (45%, 76%) 67% ( 2%, 89%) Conclusions: IDV provided clinical and surrogate marker benefit in both males and females. 60359 Nurses education in occupational HIV transmission Anna Bamford. Infection & Immunity Unit, Ealing Hospital, Uxbridge Road Southall, Middlesex, UBI 3HW, England, England Issue: Health Care Workers have a low but measurable risk of HIV infection after accidental exposure to infected blood or body fluids. Although compliance with infection control recommendations in handling sharps is the mainstay of prevention, additional prevention strategies now include post-exposure prophylaxis with anti-retroviral therapy. Project: The aim of my project was to review the latest research, data and update nurses as to what guidelines are in place and the choices of post-exposure prophylaxis that is recommended. I also collected information from questionnaires sent to nurses working on an HIV unit, to monitor their knowledge of the above issues. Results: Nurses had a good understanding of univeral precautions and risk fctors, but there was a lack of knowledge regarding transmission rates and post-exposure prophylaxis. Education is a fundamental necessity to empower a nurse with the relevant knowledge to make an informed decision regarding risk assessments in patient care. 60360[ Predictors of progression of the human immunodeficiency virus (HIV) to first opportunistic infection Denis Keohane12, D.R. Warren2, M.E. Charlson2. 1 1320 York Avenue-Apt 31-D New York, New York 10021; 2Cornell University Medical College New York NY, USA Purpose: Most predictive models for progression of HIV were developed in the 1980's and are currently not clinically relevant because of changes both in the treatment of HIV and in the disease itself. Our objective is to identify clinical variables related to occurrence of first opportunistic infection in order to create a new model for disease progression. Methods: Our study involved a retrospective longitudinal cohort of 139 HIV+ patients seen at the Cornell Internal Medicine Associates or the Center for Special Studies (dedicated HIV unit) during the calendar year 1990. 50 patients were excluded from the study because they either received less than one year of follow-up care after initial presentation or had no chart documentation of HIV disease. Clinical, laboratory and psychosocial data was recorded at baseline, yearly intervals, first opportunistic infection (01) and at death for the 89 subjects included in the study. Zerotime was established as the date of the first known positive HIV serology. For this analysis, our primary outcome is time to first 01. Results: Our study population is 60% male, mean age 36.4 years, 56% single, 45% African-american and 36% Latino. 74% had solo coverage with medicaid and 87% primarily spoke English. Risk factors for HIV were intravenous drug use (35%), heterosexual (23%) and homosexual (14%). Time to first HIV diagnosis was, on average, 1.48 years. 28% of the subjects developed an 01 with a mean time of 1.53 years. Using proportional hazards models in SAS, the following variables were identified individually as significant predictors of progression of HIV disease to first opportunistic infection: inpatient status within one year of zerotime (for any medical reason), zerotime CD4% < 10%, zerotime history of syphilis, zerotime absolute lymphocyte count <750, zerotime hemoglobin -10 and no treatment with AZT (all p < 0.05). Controlling for the total number of medications (including antiretrovirals and prophylaxis), multivariate analysis identified baseline CD4% < 10% and heterosexual risk as significant predictors of progression of HIV disease to first 01. This analysis suggests that, while controlling for the baseline HIV medications, heterosexual risk and low zerotime CD4% were strong predictors of progression of HIV disease to first opportunistic infection. Patient CD4 count Duration of cough Respiratory rate Temperature 1 6 Month 40 102.3 2 121 Unknown 32 105.1 3 34 Months 40 102.0 4 89 Month 24 102.9 Pulse 126 122 114 106 Lessons Learned: Care and treatment available to HIV-infected inmates in correctional facilities should be equivalent to that available to HIV-infected persons in the community. HIV-infected inmates should have access to clinicians experienced with HIV-care. 160358j Subgroup analysis of clinical and surrogate marker efficacy by gender in a study of indinavir (IDV) alone and with zidovudine (ZDV) in treatment-naive HIV-1 patients with 50-250 CD4 cells/mm3 Randi Leavitt', D.S. Lewi2, D. Uip3, R. Pedro4, A. Kalichman5, J. Suleiman6. Merxk Protocol 28 Study Group; ' Merck Research Laboratories BL3-4, 10 Sentry Parkway, Blue Bell, PA 19422; 2Federal Univ of Sao Paulo, Sao Paulo, SP; 3Univ of Sao Paulo Med School, Campinas, Campinas, SP; 4 Campinas State Univ Med School, Sao Paulo, SP; 5Centro de Referencia E Trenamento AIDS, Sao Paulo, SP; 6Emilio Ribas Infectious Disease Inst, Sao Paulo, SP, Brazil Objective: To investigate the consistency across gender of treatment effects on

/ 1196
Pages

Actions

file_download Download Options Download this page PDF - Pages 1041-1090 Image - Page 1065 Plain Text - Page 1065

About this Item

Title
Bridging the Gap: Conference Record [Abstract book, International Conference on AIDS (12th: 1998: Geneva, Switzerland)]
Author
International AIDS Society
Canvas
Page 1065
Publication
1998
Subject terms
abstracts (summaries)
Item type:
abstracts (summaries)

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0140.073
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0140.073/1075

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0140.073

Cite this Item

Full citation
"Bridging the Gap: Conference Record [Abstract book, International Conference on AIDS (12th: 1998: Geneva, Switzerland)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0140.073. University of Michigan Library Digital Collections. Accessed May 10, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel